Time Course of GH and IGF-1 Levels Following Withdrawal of Long-Acting Octreotide in Acromegalic Patients
2000
Aim: Several studies have demonstrated the efficacy of octreotide LAR administered intramuscularly at 4-week intervals in the treatment of acromegaly. In contrast, few data are available on the time course of GH and IGF-1 plasma levels following octreotide LAR withdrawal. This prompted us to study these parameters for up to 20 weeks following drug withdrawal in a group of 18 acromegalic patients treated for one year
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
22
References
18
Citations
NaN
KQI